Kris MG - Search Results

1

Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African Americans.

Reinersman JM, Johnson ML, Riely GJ, Chitale DA, Nicastri AD, Soff GA, Schwartz AG, Sima CS, Ayalew G, Lau C, Zakowski MF, Rusch VW, Ladanyi M, Kris MG. Reinersman JM, et al. Among authors: kris mg. J Thorac Oncol. 2011 Jan;6(1):28-31. doi: 10.1097/JTO.0b013e3181fb4fe2. J Thorac Oncol. 2011. PMID: 21107288 Free PMC article.

2

Ras oncogene point mutation: an infrequent event in bronchioloalveolar cancer.

Rusch VW, Reuter VE, Kris MG, Kurie J, Miller WH Jr, Nanus DM, Albino AP, Dmitrovsky E. Rusch VW, et al. Among authors: kris mg. J Thorac Cardiovasc Surg. 1992 Nov;104(5):1465-9. J Thorac Cardiovasc Surg. 1992. PMID: 1331621

3

Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer.

Rusch V, Klimstra D, Venkatraman E, Oliver J, Martini N, Gralla R, Kris M, Dmitrovsky E. Rusch V, et al. Cancer Res. 1995 Nov 1;55(21):5038-42. Cancer Res. 1995. PMID: 7585548

4

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer.

Miller VA, Rigas JR, Francis PA, Grant SC, Pisters KM, Venkatraman ES, Woolley K, Heelan RT, Kris MG. Miller VA, et al. Among authors: kris mg. Cancer. 1995 Feb 15;75(4):968-72. doi: 10.1002/1097-0142(19950215)75:4<968::aid-cncr2820750411>3.0.co;2-y. Cancer. 1995. PMID: 7842417 Clinical Trial.

5

Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer.

Armstrong J, Raben A, Zelefsky M, Burt M, Leibel S, Burman C, Kutcher G, Harrison L, Hahn C, Ginsberg R, Rusch V, Kris M, Fuks Z. Armstrong J, et al. Radiother Oncol. 1997 Jul;44(1):17-22. doi: 10.1016/s0167-8140(97)01907-5. Radiother Oncol. 1997. PMID: 9288852

6

Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer.

Martini N, Rusch VW, Bains MS, Kris MG, Downey RJ, Flehinger BJ, Ginsberg RJ. Martini N, et al. Among authors: kris mg. J Thorac Cardiovasc Surg. 1999 Jan;117(1):32-6; discussion 37-8. doi: 10.1016/s0022-5223(99)70467-8. J Thorac Cardiovasc Surg. 1999. PMID: 9869756 Free article.

7

Induction chemotherapy employing dose-intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma.

Ng KK, Kris MG, Ginsberg RJ, Heelan RT, Pisters KM, Miller VA, Grant SC, Bains M, Rusch V, Rosenzweig KE, Martini N. Ng KK, et al. Among authors: kris mg. Cancer. 1999 Oct 1;86(7):1189-97. doi: 10.1002/(sici)1097-0142(19991001)86:7<1189::aid-cncr13>3.0.co;2-n. Cancer. 1999. PMID: 10506703 Clinical Trial.

8

The clinical course of lung carcinoma in patients with chronic lymphocytic leukemia.

Parekh K, Rusch V, Kris M. Parekh K, et al. Cancer. 1999 Nov 1;86(9):1720-3. Cancer. 1999. PMID: 10547544

9

Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma.

Miller VA, Ng KK, Krug LM, Perez W, Pizzo B, Heelan RT, Kris MG. Miller VA, et al. Among authors: kris mg. Cancer. 2000 Mar 1;88(5):1045-50. doi: 10.1002/(sici)1097-0142(20000301)88:5<1045::aid-cncr14>3.0.co;2-j. Cancer. 2000. PMID: 10699893 Clinical Trial.

10

Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.

Sirotnak FM, Zakowski MF, Miller VA, Scher HI, Kris MG. Sirotnak FM, et al. Among authors: kris mg. Clin Cancer Res. 2000 Dec;6(12):4885-92. Clin Cancer Res. 2000. PMID: 11156248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

524 results

Search Page

Filters